






















































































































































































































































































































































































































































































































































































































Median%age%(range),%years% 15.8%(10.5Y17.1)% 1.6%(0.5Y13.8)% 2.0%(0.5Y17.1)%
Sex% Male% 2%(22)% 5%(38)% 7%(32)%
Female% 7%(78)% 8%(62)% 15%(68)%
Race% White% 9%(100)% 8%(62)% 17%(77)%
Other% 0% 5%(38)% 5%(23)%
Performance!status
a
! >12!y! ≤12!y! >12!y! ≤12!y! >12!y! ≤12!y!
8!(89)! 1!(11)! 1!(8)! 12!(92)! 9!(41)! 13!(59)!
Performance%
status%
100% 0% 1%(100)% 0% 2%(17)% 0% 3%(23)%
90% 1%(13)% 0% 1%(100)% 5%(42)% 2%(22)% 5%(38)%
80% 4%(50)% 0% 0% 2%(17)% 4%(44)% 2%(15)%
70% 2%(25)% 0% 0% 2%(17)% 2%(22)% 2%(15)%
60% 1%(13)% 0% 0% 1%(8)% 1%(11)% 1%(8)%








Second%relapse% 1%(11)% 3%(23)% 4%(18)%
% With%salvage%attempt% 1%(11)% 3%(23)% 4%(18)%
Other% 3%(33)% 3%(23)% 6%(27)%




Complete%remission% 6%(67)% 8%(62)% 14%(64)%
Partial%remission% 1%(11)% 0% 1%(5)%
Hematologic%improvement% 0% 1%(8)% 1%(5)%
Marrow%response% 1%(11)% 0% 1%(5)%
Minor%response% 1%(11)% 0% 1%(5)%
Progressive%disease% 0% 2%(15)% 2%(9)%





Yes% 1%(11)% 1%(8)% 2%(9)%
Allogeneic%BM%SCT% 1%(11)% 1%(8)% 2%(9)%
No% 8%(89)% 12%(92)% 20%(91)%
Median%time%since%initial%diagnosis%of%



























All!Grades! Grade!3/4! All!Grades! Grade!3/4! All!Grades! Grade!3/4!
Total% 6%(85.7)% 4%(57.1)% 15%(100)% 13%(86.7)% 21%(95.5)% 17%(77.3)%
Vomiting% 3%(42.9)% 0% 12%(80.0)% 1%(6.7)% 15%(68.2)% 1%(4.5)%
Pyrexia% 2%(28.6)% 1%(14.3)% 7%(46.7)% 2%(13.3)% 9%(40.9)% 3%(13.6)%
Thrombocytopenia% 0% 0% 9%(60.0)% 8%(53.3)% 9%(40.9)% 8%(36.4)%
Diarrhea% 2%(28.6)% 1%(14.3)% 6%(40.0)% 2%(13.3)% 8%(36.4)% 3%(13.6)%
Nausea% 0% 0% 7%(46.7)% 0% 7%(31.8)% 0%
ALT%increased% 1%(14.3)% 1%(14.3)% 4%(26.7)% 4%(26.7)% 5%(22.7)% 5%(22.7)%
Anemia% 0% 0% 5%(33.3)% 4%(26.7)% 5%(22.7)% 4%(18.2)%
Anxiety% 0% 0% 5%(33.3)% 0%(0.0)% 5%(22.7)% 0%
AST%increased% 1%(14.3)% 0% 4%(26.7)% 1%(6.7)% 5%(22.7)% 1%(4.5)%
Headache% 1%(14.3)% 0% 4%(26.7)% 0% 5%(22.7)% 0%
Decreased%appetite% 1%(14.3)% 1%(14.3)% 3%(20.0)% 0% 4%(18.2)% 1%(4.5)%
Hypocalcaemia% 1%(14.3)% 0% 3%(20.0)% 1%(6.7)% 4%(18.2)% 1%(4.5)%
Hypokalemia% 0% 0% 4%(26.7)% 4%(26.7)% 4%(18.2)% 4%(18.2)%
Neutropenia% 1%(14.3)% 1%(14.3)% 3%(20.0)% 2%(13.3)% 4%(18.2)% 3%(13.6)%
Cough% 0% 0% 3%(20.0)% 0% 3%(13.6)% 0%
Febrile%neutropenia% 1%(14.3)% 1%(14.3)% 2%(13.3)% 2%(13.3)% 3%(13.6)% 3%(13.6)%
Hyperbilirubinemia% 1%(14.3)% 0% 2%(13.3)% 1%(6.7)% 3%(13.6)% 1%(4.5)%
Hyponatremia% 0% 0% 3%(20.0)% 0% 3%(13.6)% 0%
Mood%altered% 0% 0% 3%(20.0)% 0% 3%(13.6)% 0%













































































































Pharmacokinetic*Parametersa* * * * * *
Midostaurin% % % % * *
Mean%AUC0C∞%(CV%),%h×ng/mL% 14365.5%(60.9)% 16463.2%(46.42)% 13016.7%(35.1)% 0.91%(0.70C1.17)% 1.26%(0.98C1.63)%
Mean%AUC0Ct%(CV%),%h×ng/mL% 13630.6%(59.24)% 15504.9%(40.80)% 12568.4%(35.28)% 0.92%(0.72C1.18)% 1.23%(0.97C1.57)%
Mean%Cmax%(CV%),%ng/mL% 1183.2%(27.2)% 1296.2%(21.11)% 1258.0%(24.6)% 1.06%(0.93C1.22)% 1.03%(0.90C1.18)%
Median%Tmax%(range),%hours% 1.3%(1.0C4.0)% 1.00%(1.0C3.0)% 1.0%(0.5C2.0)% 0.00%(C3.5C1.0)% 0.00%(C1.0C2.5)%
Mean%t1/2%(CV%),%hours% 19.3%(53.21)% 21.4%(62.68)% 13.3%(36.00)% N/A% N/A%
Mean%Cl/F%(CV%),%L/hour% 3480.5%(60.89)% 3037.0%(46.42)% 3841.2%(35.09)% N/A% N/A%
Mean%Vz/F%(CV%),%L% 97047.0%(34.85)% 93973.8%(34.18)% 74141.5%(33.08)% N/A% N/A%
Mean%Lambda%Z%(CV%),%/hour% 0.035%(53.2140)% 0.032%(62.6871)% 0.051%(36.0066)% N/A% N/A%
CGP52421% % % % % %
Mean%AUC0C∞%(CV%),%h×ng/mL% 36604.3%(26.1)% 49308.1%(57.78)% 38291.9%(48.2)% 1.05%(0.82C1.34)% 1.29%(1.01C1.65)%
Mean%AUC0Ct%(CV%),%h×ng/mL% 14948.0%(16.32)% 17084.6%(11.46)% 16339.2%(21.87)% 1.09%(0.99C1.20)% 1.05%(0.95C1.15)%
Mean%Cmax%(CV%),%ng/mL% 217.9%(16.9)% 258.9%(22.70)% 248.6%(20.0)% 1.14%(1.02C1.28)% 1.04%(0.93C1.17)%
Median%Tmax%(range),%hours% 4.0%(2.0C8.0)% 4.0%(3.0C8.0)% 4.0%(1.5C8.0)% 0.00%(C6.50C6.00)% 0.00%(C5.00C6.50)%
Mean%t1/2%(CV%),%hours% 136.4%(30.52)% 167.2%(79.26)% 129.8%(62.55)% N/A% N/A%
Mean%Lambda%Z%(CV%),%/hour% 0.005%(30.5285)% 0.004%(79.2596)% 0.005%(62.5572)% N/A% N/A%
CGP62221% % % % % %
Mean%AUC0C∞%(CV%),%h×ng/mL% 23904.4%(58.2)% 28295.0%(42.63)% 23372.0%(30.0)% 0.98%(0.77C1.24)% 1.21%(0.95C1.54)%
Mean%AUC0Ct%(CV%),%h×ng/mL% 21034.7%(45.21)% 24444.7%(28.91)% 22007.3%(28.00)% 1.05%(0.87C1.26)% 1.11%(0.92C1.34)%
Mean%Cmax%(CV%),%ng/mL% 531.7%(23.4)% 616.6%(16.85)% 593.3%(16.5)% 1.12%(1.00C1.24)% 1.04%(0.93C1.16)%
Median%Tmax%(range),%hours% 3.0%(2.0C6.0)% 4.0%(2.0C6.0)% 3.0%(1.5C8.0)% 0.00%(C4.50C6.00)% 0.00%(C6.00C4.50)%
Mean%t1/2%(CV%),%hours% 30.3%(59.15)% 34.9%(53.24)% 25.7%(29.42)% N/A% N/A%










Nausea% 1%(5.6)% 4%(22.2)% 7%(38.9)% 12%(22.2)% %
Diarrhea% 0% 3%(16.7)% 3%(16.7)% 6%(11.1)% %





Headache% 0%% 1%(5.6)% 1%(5.6)% 2%(3.7)% %
Rash% 0% 2%(11.1)% 0% 2%(3.7)% %
Blood%bilirubin%increased% 0% 1%(5.6)% 0% 1%(1.9)% %
Constiption% 0% 0% 1%(5.6)% 1%(1.9)% %
Dizziness% 0% 1%(5.6)% 0% 1%(1.9)% %
Dyspnea% 0% 1%(5.6)% 0% 1%(1.9)% %
Flatulence% 0% 0% 1%(5.6)% 1%(1.9)% %
Protozoal%infection% 1%(5.6)% 0% 0% 1%(1.9)% %
Oral%herpes% 0% 0% 1%(5.6)% 1%(1.9)% %































































Patients*with*AML,*n*%* (n=9)* (n=3)* (n=9)*
FLT3`ITD`positive% 5%(56)% 1%(33)% 6*(67)*
FLT3`TKD`positive% 0% 0% 0*
FLT3`mutant–negativec% 1%(11)% 0% 1*(11)*
Missing% 3%(33)% 2%(67)% 2*(22)*
Patients*with*MLLrCALL,*n*%* (n=13)* (n=5)* (n=13)*
FLT3`ITD`positive% 0% 0% 0*
FLT3`TKD`positive& 1%(7)% 0% 1*(7)*
FLT3`mutant–negativec& 7%(54)% 4%(80)% 11*(84)*











































Low% Intermediate% ND% High% ND% ND% ND%
Very4low/4
absent%
2% ITD% Intermediate% High% ND% ND% Low% ND% ND% ND%
3% ITD% Intermediate% Intermediate% ND% ND% Very4low% Very4low% ND% Very4low%
4% ITD% Low% Intermediate% ND% Int% Very4low% Low% ND% Low%
5% ITD% Low% Intermediate% ND% High% Very4low% Very4low% ND% Low%
6% ITD%
Low% ND% ND% Low% ND% ND% ND%
Very4low/4
absent%
7% Missinga% ND% ND% ND% ND% ND% ND% ND% High%
8% Missing% ND% ND% ND% ND% ND% ND% ND% ND%




TKD% Low% ND% ND% Low% Absent% Absent% ND%
Very4low/4
absent%
11% WT% High% High% ND% ND% Average% Low% ND% High%
12% WT% High% High% ND% High% Absent% Absent% ND% Average/high%
13% WT% Intermediate% ND% ND% ND% Low/average% ND% ND% ND%
14% WT% Intermediate% ND% ND% ND% ND% ND% ND% ND%
15% WT% Low% ND% ND% ND% ND% ND% ND% ND%




detected% ND% ND% Int% Very4low% ND% ND% Average%
18% Missingb% ND% ND% ND% Int% ND% ND% ND% ND%
19% Missingb% ND% ND% ND% ND% ND% ND% ND% ND%
20% Missingb% ND% ND% ND% ND% ND% ND% ND% ND%
21% Missingb% ND% ND% ND% High% Average% ND% ND% High%



























Underdosage:%0%%to%<16%% 0.973% 0.806% 0.987% 0.879%
Targeted%toxicity:%16%%to%<33%% 0.026% 0.171% 0.012% 0.115%
Excessive%toxicity:%33%%to%100%% 0.002% 0.023% 0.000% 0.007%
Mean%(95%%probability%estimates),% % 3%(0V16)% 10%(1V33)% 3%(0V13)% 8%(1V26)%
bid,%twice%daily.%
% %
ZWAAN%et%al.% % MIDOSTAURIN%IN%PEDIATRIC%R/R%ACUTE%
LEUKEMIA%
Outline(
%
Supplemental*Figure*1.*Overall*survival*
%
%
ALL,%acute%lymphoblastic%leukemia[%AML,%acute%myeloid%leukemia[%FLT3,%FmsVlike%tyrosine%kinase%3[%ITD,%
internal%tandem%duplication[%MLLr,%mixed%lineage%leukemia%gene%rearrangements[%OS,%overall%survival.%
% %
ZWAAN%et%al.% % MIDOSTAURIN%IN%PEDIATRIC%R/R%ACUTE%
LEUKEMIA%
Outline(
%
Supplemental*Figure*2.*Pharmacokinetics*of*midostaurin*(A)*and*its*metabolites:*CGP62221*(B)*
and*CGP52421*(C)*
A*
*
B*
*
ZWAAN%et%al.% % MIDOSTAURIN%IN%PEDIATRIC%R/R%ACUTE%
LEUKEMIA%
Outline(
%
C*
%
Data%are%only%from%patients%with%nonVmissing%values.%Data%shown%at%each%point%are%the%mean%±%SD%from%
2V6%patients%in%the%30%mg/m2%bid%cohort%and%5V13%patients%in%the%60%mg/m2%bid%cohort.%
SD,%standard%deviation[%bid,%twice%daily.%
%
